Skip to content
Luminist Labs logo

Luminist Labs

Luminist Labs is a YC Winter 2016 (W16) company. Based in Newark, CA, USA. Team of 2.

  • Medical Devices
  • Diagnostics
  • Genomics

About Luminist Labs

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Luminist Labs built a blood-based, non-invasive test to detect and stage liver fibrosis and non-alcoholic steatohepatitis at an early point in disease progression, replacing the need for a liver biopsy. The product targets clinicians who need to assess liver disease severity without a surgical procedure. Luminist Labs was acquired by DiscernDx in 2020.

From the Y Combinator listing

How Luminist Labs describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Diagnostic platform for early detection of liver disease

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
Newark, CA, USA
Team size
2
Status
Acquired
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works